tiprankstipranks
Agios Pharmaceuticals (AGIO)
NASDAQ:AGIO
US Market
AGIO
Agios Pharma
RESEARCH TOOLSreports
Want to see AGIO full AI Analyst Report?

Agios Pharma (AGIO) Stock News & Sentiment

690 Followers
Tessa Romero Reiterates Hold on Agios Pharma as Mitapivat Momentum Balances Competitive and Regulatory Uncertainties
Premium
Ratings
Tessa Romero Reiterates Hold on Agios Pharma as Mitapivat Momentum Balances Competitive and Regulatory Uncertainties
8d ago
AGIO
Agios Pharmaceuticals Earnings Call Signals Strong Momentum
Premium
Company Announcements
Agios Pharmaceuticals Earnings Call Signals Strong Momentum
20d ago
AGIO
Is AGIO a Buy, Before Earnings?
Premium
Pre-Earnings
Is AGIO a Buy, Before Earnings?
24d ago
AGIO
Maintaining Buy on Agios: Mitapivat’s Risk-Adjusted Upside Despite Etavopivat Competition and Regulatory Uncertainty
Premium
Ratings
Maintaining Buy on Agios: Mitapivat’s Risk-Adjusted Upside Despite Etavopivat Competition and Regulatory Uncertainty
30d ago
AGIO
Agios Pharmaceuticals: Mitapivat’s Early-Mover Advantage and Diversified Pipeline Support Buy Rating Despite Emerging Sickle Cell Competition
Premium
Ratings
Agios Pharmaceuticals: Mitapivat’s Early-Mover Advantage and Diversified Pipeline Support Buy Rating Despite Emerging Sickle Cell Competition
1M ago
AGIO
Agios Pharmaceuticals: Mitapivat’s Accelerated Approval Path and De-Risked Sickle Cell Opportunity Support Buy Rating
Premium
Ratings
Agios Pharmaceuticals: Mitapivat’s Accelerated Approval Path and De-Risked Sickle Cell Opportunity Support Buy Rating
2M ago
AGIO
Agios Pharmaceuticals Signals Confident Path After AQVESME Win
Premium
Company Announcements
Agios Pharmaceuticals Signals Confident Path After AQVESME Win
3M ago
AGIO
More AGIO News >

AGIO News on the Web

Agios Pharma (AGIO) Receives a Buy from Bank of America Securities
TipRanks News
Neutral
Agios Pharmaceuticals price target raised to $36 from $31 at JPMorgan
TipRanks News
Neutral
AGIO Rises on Mitapivat Progress Toward Accelerated Approval in SCD
Zacks
Bullish
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks News
Bullish
Agios Pharmaceuticals price target raised to $32 from $28 at Goldman Sachs
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: Omeros (OMER) and Agios Pharma (AGIO)
TipRanks News
Bullish
Agios Pharmaceuticals (AGIO) Moves 14.3% Higher: Will This Strength Last?
Zacks
Bullish
Leerink says Agios’ filing reinforces FDA flexibility ahead of Fulcrum update
TipRanks News
Neutral

News Score - Last 7 Days

Very Positive
AGIO
Sector Average
Media Buzz
This Week2 articles
Weekly Average7.5 articles
News Sentiment
This Week99%
Sector Average76%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is AGIO’s Media Buzz Sentiment?
2 articles about AGIO were published this week. In an average week, 7.5 articles are published.
    What is AGIO’s weekly average amount of articles?
    In an average week, 7.5 articles about AGIO are published.
      What is AGIO’s News Sentiment?
      99% of articles about AGIO were positive this week, compared to its sector average of 76%.
        Healthcare Stocks that are Trending in the News
        GOSSGossamer Bio
        RLAYRelay Therapeutics
        CGENCompugen
        ROIVRoivant Sciences
        PROKProKidney
        Showing the stocks with the most bullish news sentiment over the past week